AZD-1979

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAZD-1979
Drug Alias NameAZD-1979
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H3 receptor antagonistsMelanin-concentrating hormone receptor 1 inhibitors
TargetsHistamine H3 receptorMelanin-concentrating hormone receptor 1
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Pharmaceutical Co Ltd
Inactive CompaniesAstrazeneca Plc
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A